ADVERTISEMENT
Today: The CDC gives the green light for the Pfizer vaccine for people 12-15, the House drug pricing bill hits some speed bumps and a panel of experts blasts the global COVID-19 response.
Let’s start with the CDC:
CDC signs off on Pfizer vaccine for adolescents aged 12-15
The CDC director adopted recommendations from an advisory panel on Wednesday to clear the way for vaccinations to begin in people aged 12-15.
Significance: The highly anticipated decision is a key step toward ensuring middle and high schools can operate for full in-person learning in the fall and a major boon to parents concerned about the safety of summer activities.
Welcome to Wednesday's Overnight Health Care. More than a year into pandemic restrictions, we thought we'd seen it all. But in D.C., while indoor weddings are allowed, it's illegal to dance. Footloose comparisons are fair game.If you have any tips, email us at nweixel@thehill.com, psullivan@thehill.com, and jcoleman@thehill.com Follow us on Twitter at @NateWeixel, @PeterSullivan4, and @JustineColeman8 Today: The White House will back a World.
The U.S. will begin participating in World Trade Organization (WTO) negotiations over the exact language of the waiver, which supporters say would make the details of vaccine production widely available and allow lower-income countries to make doses themselves. The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines, Tai said.
ADVERTISEMENT
What s waived: The argument centers on temporarily lifting patent and other intellectual property protections to help expand the production and deployment of vaccines during supply shortages. The aim is to suspend the rules until the end of the pandemic.